• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT LABORATORIES TOTAL BILIRUBIN; DIAZO COLORIMETRY, BILIRUBIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT LABORATORIES TOTAL BILIRUBIN; DIAZO COLORIMETRY, BILIRUBIN Back to Search Results
Model Number 6L45-21
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 11/20/2020
Event Type  malfunction  
Manufacturer Narrative
Patient identifier: sid: (b)(6).All available patient information has been included.No additional patient details are available.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
The customer reported falsely elevated architect total bilirubin results on a (b)(6)-year-old female patient.The results generated on (b)(6) 2020 were: sid: (b)(6); initial result = 150.5 umol/l, retested on another instrument = 14 umol/l (reference range: <30umol/l).No impact to patient management was reported.
 
Manufacturer Narrative
A review of tickets determined that there is normal complaint activity for lot 55933uq09.Return testing was not completed as returns were not available.Review of tracking and trending reports did not identify any related trends for the issue for the product.File sample analysis was not performed as the issue appears to be specific to the patient sample and/or the reagent cartridge.After the reagent cartridge was replaced, the patient sample gave a normal result and quality control (qc) results were within expected ranges.Review of other patient samples from the day of the issue found this issue did not recur.In addition, historical performance was reviewed using worldwide data for the total bilirubin assay which shows complaint lot 55933uq09 is performing as expected in the field.A review of the manufacturing documentation did not identify any issues associated with the customer's observation.A review of the product labeling concluded that the issue is sufficiently addressed.Based on the investigation, no product deficiency was identified for the total bilirubin reagent (ln 6l45-21) lot 55933uq09.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TOTAL BILIRUBIN
Type of Device
DIAZO COLORIMETRY, BILIRUBIN
Manufacturer (Section D)
ABBOTT LABORATORIES
1915 hurd drive
irving TX 75038
MDR Report Key10899176
MDR Text Key218977662
Report Number3016438761-2020-00313
Device Sequence Number1
Product Code CIG
UDI-Device Identifier00380740011369
UDI-Public00380740011369
Combination Product (y/n)N
PMA/PMN Number
K121985
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 12/16/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/28/2021
Device Model Number6L45-21
Device Catalogue Number06L45-21
Device Lot Number55933UQ09
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 11/20/2020
Initial Date FDA Received11/24/2020
Supplement Dates Manufacturer Received12/16/2020
Supplement Dates FDA Received12/16/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARC C16K PRC MOD, 03L77-01, C1600969.; ARC C16K PRC MOD, 03L77-01, C1600969.
Patient Age60 YR
-
-